Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio3D Technologies was a Singapore-based private company developing scientific 3D printing and bioprinting systems for research and biomedical applications. The company described itself as a pioneer in biological 3D printing and marketed platforms intended to print living cells, tissues, and other biomaterials for use in research, diagnostics, personalized medicine, and drug development workflows. Public company-directory sources identify products including the Bio3D Life-Printer and the foldable Bio3D Explorer bioprinter. The business appears to have focused on selling enabling instrumentation rather than advancing a therapeutic drug pipeline. More recent startup-database sources indicate the company is no longer active, despite some directories still listing it as active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bio3D Technologies.